Tag Archives: DEX

Top 5 Undervalued Stocks To Invest In Right Now

Uber has agreed to pay 56 current and former employees about $33,900 each, or $1.9 million, to settle their claims of gender discrimination, harassment and hostile work environment.

On Monday, lawyers for the plaintiffs filed paperwork in a Northern California district court that outlined how much the $10 million settlement, announced in April, would go to the current and former staffers involved in the suit.

The lawsuit was filed against Uber in October 2017 by three Latina engineers who alleged they were paid less than their white or Asian male colleagues. The women claimed Uber used a discriminatory “stack ranking” system, alleging “female employees and employees of color are systematically undervalued … because [they] receive, on average, lower rankings despite equal or better performance.”

Those stack rankings were then used, in part, to determine promotions, according to the lawsuit. Uber also set employee pay based on their past compensation, which inherently disadvantages women.

Top 5 Undervalued Stocks To Invest In Right Now: Foamix Pharmaceuticals Ltd.(FOMX)

Advisors’ Opinion:

  • [By Max Byerly]

    HC Wainwright set a $11.00 price target on Foamix Pharmaceuticals (NASDAQ:FOMX) in a research note released on Tuesday. The firm currently has a buy rating on the specialty pharmaceutical company’s stock.

  • [By Stephan Byrd]

    Press coverage about Foamix Pharmaceuticals (NASDAQ:FOMX) has trended somewhat positive this week, according to Accern Sentiment. Accern identifies positive and negative media coverage by reviewing more than 20 million news and blog sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores closest to one being the most favorable. Foamix Pharmaceuticals earned a news impact score of 0.14 on Accern’s scale. Accern also assigned press coverage about the specialty pharmaceutical company an impact score of 45.4298608245084 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the stock’s share price in the near term.

  • [By Joseph Griffin]

    Headlines about Foamix Pharmaceuticals (NASDAQ:FOMX) have been trending somewhat positive recently, according to Accern. The research group rates the sentiment of press coverage by analyzing more than 20 million news and blog sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Foamix Pharmaceuticals earned a media sentiment score of 0.15 on Accern’s scale. Accern also gave news headlines about the specialty pharmaceutical company an impact score of 47.5479155329096 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the stock’s share price in the immediate future.

  • [By Ethan Ryder]

    News headlines about Foamix Pharmaceuticals (NASDAQ:FOMX) have trended somewhat positive recently, Accern reports. Accern rates the sentiment of media coverage by analyzing more than twenty million blog and news sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Foamix Pharmaceuticals earned a news impact score of 0.15 on Accern’s scale. Accern also assigned press coverage about the specialty pharmaceutical company an impact score of 48.1562748121044 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the stock’s share price in the near term.

Top 5 Undervalued Stocks To Invest In Right Now: The Gabelli Healthcare & Wellness Trust(GRX)

Advisors’ Opinion:

  • [By Shane Hupp]

    GOLD Reward Token (CURRENCY:GRX) traded 2% higher against the US dollar during the twenty-four hour period ending at 12:00 PM ET on July 22nd. GOLD Reward Token has a market capitalization of $0.00 and $0.00 worth of GOLD Reward Token was traded on exchanges in the last 24 hours. One GOLD Reward Token token can now be bought for about $0.0041 or 0.00000055 BTC on cryptocurrency exchanges including Livecoin and CoinExchange. Over the last week, GOLD Reward Token has traded down 10.8% against the US dollar.

  • [By Stephan Byrd]

    GOLD Reward Token (CURRENCY:GRX) traded flat against the US dollar during the 24-hour period ending at 23:00 PM ET on June 25th. In the last seven days, GOLD Reward Token has traded 2.6% lower against the US dollar. One GOLD Reward Token token can now be bought for approximately $0.0050 or 0.00000080 BTC on popular cryptocurrency exchanges including Livecoin and CoinExchange. GOLD Reward Token has a market cap of $0.00 and $3.00 worth of GOLD Reward Token was traded on exchanges in the last 24 hours.

  • [By Max Byerly]

    Headlines about Gabelli Healthcare & WellnessRx Trust Closed-Ended Fund (NYSE:GRX) have been trending positive on Monday, Accern Sentiment reports. Accern identifies positive and negative media coverage by reviewing more than 20 million news and blog sources in real time. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Gabelli Healthcare & WellnessRx Trust Closed-Ended Fund earned a coverage optimism score of 0.38 on Accern’s scale. Accern also assigned news articles about the investment management company an impact score of 45.0228414962591 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the company’s share price in the near term.

  • [By Stephan Byrd]

    GOLD Reward Token (CURRENCY:GRX) traded down 3% against the U.S. dollar during the 1 day period ending at 13:00 PM ET on July 1st. During the last week, GOLD Reward Token has traded flat against the U.S. dollar. One GOLD Reward Token token can currently be purchased for $0.0044 or 0.00000070 BTC on popular exchanges including CoinExchange and Livecoin. GOLD Reward Token has a total market capitalization of $0.00 and approximately $1.00 worth of GOLD Reward Token was traded on exchanges in the last 24 hours.

Top 5 Undervalued Stocks To Invest In Right Now: CNB Financial Corporation(CCNE)

Advisors’ Opinion:

  • [By Max Byerly]

    BidaskClub upgraded shares of CNB Financial (NASDAQ:CCNE) from a hold rating to a buy rating in a research note released on Wednesday morning.

    Several other equities research analysts have also issued reports on CCNE. Boenning Scattergood reissued a buy rating and set a $29.50 price target on shares of CNB Financial in a research report on Monday, February 5th. Zacks Investment Research lowered CNB Financial from a buy rating to a sell rating in a research report on Tuesday, February 20th. ValuEngine raised CNB Financial from a buy rating to a strong-buy rating in a research report on Monday, April 2nd. Finally, Keefe, Bruyette & Woods initiated coverage on CNB Financial in a research report on Tuesday, April 10th. They set a market perform rating and a $35.00 price target on the stock. One research analyst has rated the stock with a sell rating, one has given a hold rating and three have given a buy rating to the company. The stock presently has an average rating of Hold and an average target price of $31.50.

  • [By Ethan Ryder]

    CNB Financial (NASDAQ:CCNE) was downgraded by research analysts at BidaskClub from a “sell” rating to a “strong sell” rating in a research report issued to clients and investors on Friday.

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on CNB Financial (CCNE)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 5 Undervalued Stocks To Invest In Right Now: Old National Bancorp Capital Trust I(ONB)

Advisors’ Opinion:

  • [By Max Byerly]

    Get a free copy of the Zacks research report on Old National Bancorp (ONB)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Ethan Ryder]

    Bank of New York Mellon Corp lifted its stake in shares of Old National Bancorp (NASDAQ:ONB) by 1.7% in the second quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 3,451,745 shares of the bank’s stock after buying an additional 57,759 shares during the quarter. Bank of New York Mellon Corp’s holdings in Old National Bancorp were worth $64,203,000 at the end of the most recent reporting period.

  • [By Max Byerly]

    Russell Investments Group Ltd. reduced its holdings in shares of Old National Bancorp (NASDAQ:ONB) by 31.0% in the 1st quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 441,479 shares of the bank’s stock after selling 198,314 shares during the quarter. Russell Investments Group Ltd. owned approximately 0.29% of Old National Bancorp worth $7,461,000 as of its most recent filing with the SEC.

  • [By Shane Hupp]

    SG Americas Securities LLC grew its position in Old National Bancorp (NASDAQ:ONB) by 122.1% in the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 150,316 shares of the bank’s stock after buying an additional 82,641 shares during the period. SG Americas Securities LLC’s holdings in Old National Bancorp were worth $2,796,000 at the end of the most recent quarter.

Top 5 Undervalued Stocks To Invest In Right Now: Delaware Enhanced Global Dividend(DEX)

Advisors’ Opinion:

  • [By Max Byerly]

    DEX (CURRENCY:DEX) traded 17.7% lower against the U.S. dollar during the 1-day period ending at 19:00 PM E.T. on February 16th. One DEX token can currently be purchased for $0.0382 or 0.00001051 BTC on popular cryptocurrency exchanges including IDAX and Coinbit. DEX has a market cap of $7.31 million and $2.95 million worth of DEX was traded on exchanges in the last day. Over the last week, DEX has traded 28.8% lower against the U.S. dollar.